MoneyWorks4Me

Jenburkt Pharmaceuticals submits daily report

12 Jan 2023 Evaluate

Pursuant to provisions of Regulation 18(i) of the Buy-back Regulations, Jenburkt Pharmaceuticals has submitted the daily report with respect to Equity Shares bought back by the Company on 12th January, 2023. The details will also be made available on the website of the Company: www.jenburkt.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..